Nye 1,3,5-triazinderivater som ligander for humane adenosin-A3-reseptorer, og farmasøytiske sammensetninger som inneholder slike

The invention relates to a group of novel triazine derivatives which are ligands for human adenosine-A3 receptors, as well as to pharmaceutical compositions containing a pharmacologically active amount of at least one of these compounds as an active ingredient. The invention relates to compounds of...

Full description

Saved in:
Bibliographic Details
Main Authors Pras-Raves, Maria L, Scharrenburg, Gustaaf Johan Marie van, Gustafson, Gary R, Reinders, Jan J, Hartog, Jacobus Antonius Jeseph den
Format Patent
LanguageNorwegian
Published 02.02.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a group of novel triazine derivatives which are ligands for human adenosine-A3 receptors, as well as to pharmaceutical compositions containing a pharmacologically active amount of at least one of these compounds as an active ingredient. The invention relates to compounds of the general formula (1), wherein Y represents a group of the general formula (A), (B) or (C), and all other symbols have the meanings as given in the description.
Bibliography:Application Number: NO20040000397